Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

26 Jun 2023

Abstract excerpt

BACKGROUND: Solute carrier family 25 member 32 (SLC25A32) is an important member of SLC25A family and plays a role in folate transport metabolism. However, the mechanism and function of SLC25A32 in the progression of human glioblastoma (GBM) remain unclear. METHODS: In this study, folate related gene analysis was performed to explore gene expression profiles in low-grade glioma (LGG) and GBM. Western blotting,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Enzymes and Metabolism
Share to Folate and B Vitamins Research
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37365560
DOI: 10.1186/s12885-023-11097-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathwayPMID 37365560Read ↗

SLC43A3 Promotes Oncogenesis and Predicts Poor Prognosis in GliomaSemantic proximity Read ↗

SLC12A5 as a novel potential biomarker of glioblastoma multiformeSemantic proximity Read ↗

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasSemantic proximity Read ↗

SLC39A1 Contribute to Malignant Progression and Have Clinical Prognostic Impact in GliomasSemantic proximity Read ↗

A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype.Semantic proximity Read ↗

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axisSemantic proximity Read ↗

High Expression of RAB32 Predicts Adverse Outcomes: A Potential Therapeutic Target for GlioblastomaSemantic proximity Read ↗

MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.Semantic proximity Read ↗

SLC6A6 alleviates cellular senescence in glioblastoma via the CSK/AKT/FoxO1 signalingSemantic proximity Read ↗

SLC34A2 regulates miR‐25‐Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell‐like cellsSemantic proximity Read ↗

Mitochondria-associated gene SLC25A32 as a novel prognostic and immunotherapy biomarker: From pan-cancer multi-omics analysis to breast cancer validationSemantic proximity Read ↗

IGF2BP2 modulates autophagy and serves as a prognostic marker in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.